乐天堂fun88

Shenzhen Cell Valley Makes Debut at Pingshan-Brazil Economic and Trade Matching Event to Explore Latin American Cell Therapy Market New opportunities

Date:11-06  Hits:  Belong to:News & Events




The "Pingshui Xiangfeng · Shanhai Gongshang" China-Brazil Pharmaceutical Trade and Economic Matching Activity, led by the Pingshan District Commerce Bureau and organized by the Shenzhen Pingshan Cross-border Trade and Investment Service Center, was held at the Yanzi Lake International Convention and Exhibition Center in Pingshan District. The President of the Chinese Association of Campinas, Brazil, led a delegation from a hospital group and medical device distributors to visit, focusing on seeking partners in the fields of cell and gene therapy, medical consumables, and AI-assisted diagnosis and treatment.



The "South China Cell Factory" project at Shenzhen Cell Valley, as a key initiative in the cell and gene therapy industry of Pingshan District and a major public technology service platform project in Shenzhen, was invited to participate in the exhibition. Dr. Fu Yuchen, Assistant to the Chairman, and Han Shu, Director of the Deep Harbour Cell Valley Office, systematically explained the company's core advantages and recent pipeline to the Brazilian delegation. They also showcased the full-process service of "viral vector—cell preparation—registration application—talent training" supported by China's first industrial-grade GMP production line for retroviral vectors. The presentation sparked significant interest, with multiple Brazilian hospitals and distributors expressing cooperation intentions and inviting the company for in-depth discussions in Brazil.

 

The Brazilian delegation and the organizer's representative jointly stated that this event would serve as a starting point to establish a regular cooperation platform, providing customized' Latin America Export' service packages for high-quality enterprises such as Shenzhen Cell Valley, and jointly exploring new blue oceans in the Latin American cell therapy market.

 

 



take a group photo to mark the occasion




About Us
Scan to follow our latest newsScan to follow our latest news
Contact Us
400-800-1266

Working hours: Monday to Friday, 9:00-18:00

Contact:Ms. Lai

Email:laijiaqi@wfzydp.com

Address:No. 1, Rongtian Road, Jinsha Community, Kengzi Street, Pingshan District, Shenzhen, China (Hepure Biomedical Ecological Park)

Shenzhen Cell Valley Biopharmaceutical Co., Ltd. is a leading one-stop comprehensive outsourcing service provider for China’s cell and gene therapy industry. It is also among the first domestic CRO/CDMO enterprises to hold GMP-compliant industrial production capabilities for clinical-grade retroviral vectors. As a key project for the construction of Shenzhen’s public technical service platform for CRO/CDMO, the company has been listed in the city’s newly announced "20+8" strategic emerging industries initiative.
Shenzhen Cell Valley is equipped with the capacity to conduct standardized and industrialized production of GMP-grade cellular products including CAR-T cells. Its core production lines cover a full spectrum of cellular products such as CAR-T, CAR-NK, CAR-M, γδT, TIL and TCR-T. In addition, the company runs production lines for a diverse range of viral vectors (including RVV, LVV and AAV) and non-viral vectors, as well as for cellular raw materials for therapeutic development—such as exosomes, genetically engineered antibodies, cytokines, oncolytic viruses and vaccines.
 Copyright 粤ICP备2024168379号 互联网药品信息服务资格证书:(粤)-非经营性-2022-0426  Technical Support:YouDian Software